Overview of the trials registered in the database Clinical Trials (ClinicalTrails.gov) for the use of aromatase, STS and HSD17B1 inhibitors in breast, endometrial, ovarian, prostate cancers and endometriosis. Here, HSD17B1 is linked to prostate carcinoma.